Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Epilepsy and Related Neuropsychiatric Comorbidities: Basic and Clinical Research

Author(s): Rita Citraro and Antonio Leo

Volume 21, Issue 8, 2023

Page: [1632 - 1633] Pages: 2

DOI: 10.2174/1570159X2108230510162504

Price: $65

« Previous Next »
[1]
Thijs, R.D.; Surges, R.; O’Brien, T.J.; Sander, J.W. Epilepsy in adults. Lancet, 2019, 393(10172), 689-701.
[http://dx.doi.org/10.1016/S0140-6736(18)32596-0]
[2]
Kanner, A.M. Management of psychiatric and neurological comorbidities in epilepsy. Nat. Rev. Neurol., 2016, 12(2), 106-116.
[http://dx.doi.org/10.1038/nrneurol.2015.243]]
[3]
Terrone, G.; Pauletti, A.; Pascente, R.; Vezzani, A. Preventing epileptogenesis: A realistic goal? Pharmacol. Res., 2016, 110, 96-100.
[http://dx.doi.org/10.1016/j.phrs.2016.05.009]
[4]
Perucca, P.; Scheffer, I.E.; Kiley, M. The management of epilepsy in children and adults. MJA, 2018, 208(5), 226-233.
[http://dx.doi.org/10.5694/mja17.00951]
[5]
Neri, S.; Gasparini, S.; Pascarella, A.; Santangelo, D.; Cianci, V.; Mammì, A. Epilepsy in cerebrovascular diseases: A narrative review. Curr. Neuropharmacol., 2022, 21, 1634-1645.
[http://dx.doi.org/10.2174/1570159X20666220706113925]
[6]
Leo, A.; De Caro, C.; Nesci, V.; Tallarico, M.; De Sarro, G.; Russo, E. Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy. Epilepsy Behav., 2020, 104(Pt B), 106472.
[7]
Ferlazzo, E.; Gasparini, S.; Beghi, E.; Sueri, C.; Russo, E.; Leo, A. Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors. Epilepsia, 2016, 57(8), 1205-1214.
[8]
Felicia, F.; Pastorino, G.M.G.; Viggiano, A.; Dell’Isola, G.B.; Dini, G.; Verrotti, A. Epilepsy and cognitive impairment in childhood and adolescence: A mini-review. Curr. Neuropharmacol., 2022, 21, 1646-1665.
[http://dx.doi.org/10.2174/1570159X20666220706102708]]
[9]
Leo, A.; Citraro, R.; Tallarico, M.; Iannone, M.; Fedosova, E.; Nesci, V. Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2019, 94, 109652.
[10]
Pisani, F.; Rosa, P.L.; Barbieri, M.A.; de Leon, J.; Spina, E. Optimization of therapy in patients with epilepsy and psychiatric comorbidities: Key points. Curr. Neuropharmacol., 2022, 21, 1755-1766.
[http://dx.doi.org/10.2174/1570159X20666220526144314]]
[11]
Tallarico, M.; Pisano, M.; Leo, A.; Russo, E.; Citraro, R.; De Sarro, G. Antidepressants drugs for seizures and epilepsy: Where do we stand? Curr. Neuropharmacol., 2022, 21, 1691-1713.
[12]
Mula, M.; Brodie, M.J.; de Toffol, B.; Guekht, A.; Hecimovic, H.; Kanemoto, K. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia, 2022, 63(2), 316-334.
[http://dx.doi.org/10.1111/epi.17140]]
[13]
Zaccara, G.; Franco, V. Pharmacokinetic interactions between antiseizure and psychiatric medications. Curr. Neuropharmacol., 2022, 21, 1666-1690.
[http://dx.doi.org/10.2174/1570159X20666220524121645]]
[14]
Miziak, B.; Czuczwar, S.J.; Pluta, R. Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions. Front. Pharmacol., 2022, 13, 988716.
[15]
Roberti, R.; Palleria, C.; Nesci, V.; Tallarico, M.; Di Bonaventura, C.; Cerulli, I.E. Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opin. Drug Metab. Toxicol., 2020, 16(10), 983-995.
[http://dx.doi.org/10.1080/17425255.2020.1806236]]
[16]
Fortunato, F.; Giugno, A.; Sammarra, I.; Labate, A.; Gambardella, A. Epilepsy, immunity and neuropsychiatric disorders. Curr. Neuropharmacol., 2022, 21, 1714-1735.
[17]
Tan, T.H.L.; Perucca, P.; O’Brien, T.J.; Kwan, P.; Monif, M. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease. Epilepsia, 2021, 62(2), 303-324.
[18]
Rollo, E.; Romozzi, M.; Vollono, C.; Calabresi, P.; Geppetti, P.; Iannone, L.F. Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era. Curr. Neuropharmacol., 2022, 21, 1767-1785.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy